Plooster Matthew R
SEC CIK 1638364 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | Dir | 18.5K | $71.0K | — | 3 | 2021-12-01 | 2023-03-09 |
Most active insiders at ZVRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McFarlane Neil F. | Pres, CEO, Dir | — | $1.19M |
| 2 | Thompson Rahsaan | Chief Legal, Compliance, Sec | — | $969.4K |
| 3 | Watton Corey Michael | Dir | — | $138.4K |
| 4 | Schafer Joshua | CCO | — | $126.3K |
| 5 | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | — | $43.0K |
| 6 | Quartel Adrian W | Chief Medical Off | — | $40.0K |
| 7 | Bode John B | Dir | — | — |
| 8 | Clifton R. LaDuane | Former CFO, Treas | — | — |
Plooster Matthew R made no open-market trades at ZVRA in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-13 | 2023-03-09 | ZVRA | ZEVRA THERAPEUTICS, INC. | Plooster Matthew R | Dir | P - Purchase | $4.20 | +11.0K | 18.5K | +147% | +$46.2K | |
| M | 2022-05-18 | 2022-05-18 | ZVRA | ZEVRA THERAPEUTICS, INC. | Plooster Matthew R | Dir | P - Purchase | $4.96 | +5,000 | 7,161 | +231% | +$24.8K |
| 2021-12-01 | 2021-12-01 | ZVRA | ZEVRA THERAPEUTICS, INC. | Plooster Matthew R | Dir | A - Grant | $8.44 | +2,500 | 2,500 | New | +$21.1K |
Purchase Sale Sale after option exercise All abbreviations